Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-away
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Probiotics Dietary Supplements Market Insights
3.1. Probiotics dietary supplements industry snapshot
3.2. Probiotics dietary supplements value chain & distribution analysis
3.3. Probiotics dietary supplements market dynamics
3.3.1. Probiotics dietary supplements Market driver analysis
3.3.2. Probiotics dietary supplements Market restraint/challenges analysis
3.3.3. Probiotics dietary supplements Market opportunity analysis
3.4. Industry analysis - Porter's five force
3.5. Probiotics dietary supplements market PEST analysis, 2017
3.6. Probiotics dietary supplements industry trends
3.7. Competitive company ranking analysis
4. Probiotics Dietary Supplements Market Size and Forecast, By Application
4.1. Key Findings
4.2. Food Supplements
4.3. Nutritional Supplements
4.4. Specialty Nutrients
4.5. Infant Formula
4.6. Others
5. Probiotics Dietary Supplements Market Size and Forecast by Regions
5.1. Key findings
5.2. North America
5.2.1. U.S.
5.2.2. Canada
5.3. Europe
5.3.1. UK
5.3.2. Germany
5.3.3. France
5.3.4. Italy
5.4. Asia Pacific
5.4.1. China
5.4.2. India
5.4.3. Japan
5.4.4. Australia
5.5. Latin America
5.5.1. Brazil
5.5.2. Mexico
5.6. Middle East & Africa
6. Company Profiles
6.1. BioGaia AB
6.1.1. Overview
6.1.2. Financials
6.1.3. Product Benchmarking
6.1.4. Recent Developments
6.2. NutraScience Labs
6.2.1. Overview
6.2.2. Financials
6.2.3. Product Benchmarking
6.2.4. Recent Developments
6.3. Winclove Probiotics BV
6.3.1. Overview
6.3.2. Financials
6.3.3. Product Benchmarking
6.3.4. Recent Developments
6.4. Probi AB
6.4.1. Overview
6.4.2. Financials
6.4.3. Product Benchmarking
6.4.4. Recent Developments
6.5. Nutraceutix
6.5.1. Overview
6.5.2. Financials
6.5.3. Product Benchmarking
6.5.4. Recent Developments
6.6. AB Biotics
6.6.1. Overview
6.6.2. Financials
6.6.3. Product Benchmarking
6.6.4. Recent Developments
6.7. Probiotical SpA
6.7.1. Overview
6.7.2. Financials
6.7.3. Product Benchmarking
6.7.4. Recent Developments
6.8. ProbioFerm
6.8.1. Overview
6.8.2. Financials
6.8.3. Product Benchmarking
6.8.4. Recent Developments
6.9. Lallemand
6.9.1. Overview
6.9.2. Financials
6.9.3. Product Benchmarking
6.9.4. Recent Developments
6.10. Protexin
6.10.1. Overview
6.10.2. Financials
6.10.3. Product Benchmarking
6.10.4. Recent Developments